Healthcare Market Research Reports and Trends

The report  “ Sports Medicine Market  by Product (Body Reconstruction (Arthroscopy devices, Implants), Body Support & Recovery Products (Physiotherapy Equipment, Compression Clothing, Braces & Supports)), Application and Region – Global Forecasts to 2024″ , is expected to reach USD 9.1 billion by 2024 from USD 6.6 billion in 2019, at a CAGR of 6.5%. Growth in the sports medicine market is mainly driven by factors such as the continuous influx of new products &s treatment modalities, the increasing incidence of sports injuries, and developments in the field of regenerative medicine. The body reconstruction products segment is expected to account for the largest share of the sports medicine product market in 2019 On the basis of product, the sports medicine market is segmented into body reconstruction products (fracture & ligament repair products, arthroscopy devices, implants, prosthetics, orthobiologics), body support & recovery products (braces & support,

The global  Peripheral Vascular Devices Market  was valued at USD 10.3 billion. It is expected to reach USD 14.3 billion by 2024, at a CAGR of 6.8%. The growth of this market is due to the rapid growth in the geriatric population, rising disease prevalence, and the growing preference for minimally invasive products. The demand for these products has also shown significant growth in emerging economies. The atherectomy devices segment held the largest share in the plaque modification devices market in 2018 Based on type, the market for plaque modification devices is segmented into atherectomy devices and thrombectomy devices. Atherectomy devices held the leading share of the plaque modification devices market in 2018. This is driven largely by the increasing obesity levels worldwide and the increasing number of approvals for new products in this field. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790 Drug-eluting balloons will register the hig

Growth in the global market is mainly driven by the increasing R&D spending, technological advancements in process development, growth in the biopharmaceutical industry, and growing pressure to lower the cost of manufacturing. However, factors such as the high cost of technology and equipment in this market and lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent. The global  high throughput process development market  is expected to reach  USD 415.5 Million in 2021 from USD 162.9 Million in 2015 , at a  CAGR of 14.4%  during the forecast period. Based on technology, the market is categorized into chromatography, ultraviolet-visible spectroscopy, and others (ELISA, chip electrophoresis, SPR, and qPCR). The chromatography segment accounted for the largest share of the global market in 2016. The chromatography segment is further divided into ion exchange chromatography (IEC), affinity chromatography (AC), multimodal chromatog

Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis. The global  respiratory drug delivery market  is projected to reach  USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016 , at a  CAGR of 6.5%  during the forecast period. The respiratory drug delivery market by formulation segment is further divided into device type and formulation type. The types of respiratory drug delivery is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The dry powder inhalers segment is expected to witness the highest growth during the forecast period due to the advantages associated with the use of these inhalers, such as short administration & preparation time, ease of use, and fewer irritant effects. The respiratory drug delivery market, based on formul

Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers. The global  blood collection market  is expected to reach  USD 10.59 Billion by 2022 from USD 8.10 Billion  in 2017, at a  CAGR of 5.5%  during forecast period. The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products. Increasing disease incidence and growing number of accidents & trauma cases The prevalence of infectious diseases such as Human Papillomavirus (HPV), hepatitis, Human Immunodeficiency Virus (HIV), and tuberculosis are high despite significant improvements in sanitation and medicine. Traditionally, antimicrobial therapy was used as a powerful tool to combat infectious diseases; however, over the years, anti

According to a new market research report “ Medical Holography Market  by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) – Global Forecast to 2021 ” published by MarketsandMarkets, The Global Medical Holography Market Is Projected to Reach USD 953.9 Million by 2021, at a CAGR of 33.7% from 2016 to 2021. The growth in this market can be mainly attributed to the growing clinical applications of holography in the healthcare sector, rising adoption of holography products in biomedical research and medical education, and emergence of holography as a promising technology in representing complex 3D structures. In this report, the global Medical Holography Market is segmented on the basis of product type, application, end user, and region. Based on product type, the market is segmented into holographic displays, holography microscopes, holograp

The transition to ICD-10 coding standards from ICD-9 in North America, the growing demand for CAC solutions, the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue cycle management procedures. The  computer assisted coding market  is expanding with the emergence of new products and applications. These computer assisted coding solutions being used in many applications such as automated computer-assisted encoding, management reporting & analytics, and clinical coding auditing. Implementation of ICD-10 Drive the Global Computer Assisted Coding Market Many hospitals, especially in North America, are adopting CAC systems to manage the increasing load of coding resulting from the adoption of ICD-10 standards. Major health plans like Medicare have reported a smooth transition to ICD-10 due to rigorous testing for over six years. The ICD-10 coding system requires the use of 72,000 procedure co

The global mice model market involves use of different varieties of mice (inbred, outbred, and conditioned/surgically modified, among others) in the research studies across the globe. Mice models are widely used as research models to study human genes and human diseases. Scientists use mice models to explore various health problems and assure the safety of new medical treatments. Factors such as ongoing innovations in mice models, continuous support in the form of investments and grants, and growing demand for humanized mice models. The  mice model market  is expected to reach  USD 1.59 billion by 2021 from USD 1.11 billion in 2016 , at a  CAGR of 7.5%  from 2016 to 2021. On the basis of type, the mice model market is segmented into inbred mice, genetically engineered mice, conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice. The knockout mice models is expected to grow at the highest CAGR during the forecast period. The high grow

Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. The  vitamin D therapy market  is projected to reach  USD 3.3 billion by 2024 from USD 1.9 billion in 2019 , at a  CAGR of 11.6% . Market is segmented into oral and parenteral routes of administration. The oral route of administration is expected to register the largest share and highest CAGR during the forecast period. This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route. Market is segmented into osteoporosis, rickets, skin diseases, muscle weakness, autoimmune disorders, and other applications. The osteoporosis segment is expected to register the highest growth during the forecast period

Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. The  ligation devices market  is projected to reach  USD 1,189 million by 2024 from USD 876 million in 2019 , at a  CAGR of 6.3% . Ligation devices market is segmented into handheld instruments and accessories. The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period. This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets. Ligation devices market is segmented into gastrointestinal & abdominal surgeries, gynecological surgeries, cardiovascular surgeries, urological surgeries, and other applications such as wound, ENT, and cosmetic applications. The cardiovascular surgeries segm

Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a vascular closure device is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits. The global  vascular closure devices market  is expected to reach  USD 984.6 Million by 2022 from USD 704.8 Million in 2017 , at a  CAGR of 6.9% . Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods. Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings. Additionally, malfunctioning of devices, poor quality, and underperformance of devices are the primary causes of product recalls. Product failures and reca